Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy: A prospective study at a single institute

Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy: A prospective study at a single institute - Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy: A prospective study at a single institute

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013208

Enrollment

Registered

2014-02-21

Start date

2005-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

distal pancreatectomy

Interventions

Drain was removed on postoperative day1. For the patients with a high drain amylase level and patients with symptomatic intraperitoneal fluid collection, triple-drug therapy was introduced. Drain re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were performed distal pancreatetcomy

Exclusion criteria

Exclusion criteria: Combined with other-organ resection and postoperative intraperitoneal bleeding via the drain on the day of surgery

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of this management	—

Secondary

Measure	Time frame
Incidence of pancreatic fistula.	—

Countries

Japan

Contacts

Public ContactTomohiko Adachi

Nagasaki university Department of surgery

adatomo@nagasaki-u.ac.jp095-819-7316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026